Verona Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$54,369,000 over the previous period. Total operating expenses were $67,151,278.

Profit Margin

Verona Pharma plc (NASDAQ:VRNA): Profit margin
2014 0 -4.29M
2015 0 -10.98M
2016 0 -6.19M
2017 1.84M -27.69M -1504.6%
2018 2.78K -25.25M -907384.55%
2019 2.35K -41.87M -1781367.46%
2020 0 -65.14M
2021 40M -55.56M -138.92%
2022 458K -68.70M -15000.22%
2023 0 -54.36M

VRNA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0458K40M02.35K2.78K1.84M000
Cost of revenue
679.62K346K0627.84K512.11K00000
Gross profit
-679.62K112K40M-627.84K-509.76K2.78K1.84M000
Operating exp.
Research and development
17.28M49.28M79.40M44.50M43.89M24.48M32.05M5.57M10.76M4.10M
Selling and marketing
019.38M22.24M0000000
Total operating expenses
67.15M66.22M97.68M66.01M53.41M32.48M40.16M8.48M13.29M5.90M
Operating income
-67.83M-66.11M-73.31M-74.27M-53.86M-32.47M-40.21M-8.66M-13.29M-5.90M
Other income (expenses), net
12.61M-2.33M17.72M6.78M2.46M1.85M4.55M1.29M-28K29.97K
Income before tax
-55.21M-68.44M-55.58M-65M-51.40M-30.62M-34.05M-7.36M-13.22M-5.85M
Income tax expense
-632.44K253K-18K146K-9.52M-5.37M-6.35M-1.17M-2.23M-1.56M
Net income
-54.36M-68.70M-55.56M-65.14M-41.87M-25.25M-27.69M-6.19M-10.98M-4.29M
Earnings per share
Basic EPS
-0.54-1.04-0.94-1.98-3.18-0.19-0.25-0.02-0.00-0.00
Diluted EPS
-0.54-1.04-0.94-1.98-3.18-0.19-0.25-0.02-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData source